| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/00365548.2012.681694 |
| P698 | PubMed publication ID | 22681412 |
| P2093 | author name string | Thomas R Talbot | |
| Catherine S O'Neal | |||
| Titus L Daniels | |||
| Hollis R O'Neal | |||
| P2860 | cites work | Extended-spectrum beta-lactamases: a clinical update | Q24534999 |
| A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
| National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. | Q30885076 | ||
| Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. | Q33972587 | ||
| SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacae | Q34073514 | ||
| Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome | Q34106854 | ||
| The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting | Q34509624 | ||
| Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae. | Q34510547 | ||
| Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome | Q35007119 | ||
| Utility of NCCLS guidelines for identifying extended-spectrum beta-lactamases in non-Escherichia coli and Non-Klebsiella spp. of Enterobacteriaceae | Q35552314 | ||
| High prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns. | Q36670187 | ||
| Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. | Q37043607 | ||
| Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria | Q39091495 | ||
| Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures | Q42799124 | ||
| Detection of SHV-type extended-spectrum beta-lactamase in Enterobacter isolates | Q42929547 | ||
| Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes | Q44142354 | ||
| Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin | Q44709393 | ||
| Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. | Q44877949 | ||
| Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases | Q44943295 | ||
| Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. | Q54058575 | ||
| Prevalence, microbiology, and clinical characteristics of extended-spectrum beta-lactamase-producing Enterobacter spp., Serratia marcescens, Citrobacter freundii, and Morganella morganii in Korea | Q57212092 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 726-732 | |
| P577 | publication date | 2012-06-10 | |
| P1433 | published in | Infectious Diseases | Q7429961 |
| P1476 | title | Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia | |
| P478 | volume | 44 |
| Q95409426 | A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World |
| Q26783911 | Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis |
| Q38626553 | Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis |
Search more.